Population pharmacokinetics of lamotrigine in elderly patients

被引:36
作者
Punyawudho, Baralee [1 ]
Ramsay, R. Eugene [2 ]
Macias, Flavia M. [2 ]
Rowan, A. James [3 ]
Collins, Joseph F. [4 ]
Brundage, Richard C. [1 ]
Birnbaum, Angela K. [1 ]
机构
[1] Univ Minnesota, Minneapolis, MN 55455 USA
[2] VA Med Ctr, Miami, FL USA
[3] VA Med Ctr, Bronx, NY USA
[4] VA Med Ctr, Perry Point, MD USA
关键词
NONMEM; lamotrigine; elderly; population pharmacokinetics;
D O I
10.1177/0091270007313391
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lamotrigine is being used more frequently in elderly patients. Dosing of lamotrigine in elderly patients is based largely on studies from younger adults and not evidence-based data from elderly patients. The goal of this study is to determine the pharmacokinetic parameters, such as clearance, and the factors that have a significant effect on these parameters to provide evidence-based information that can be used to dose elderly patients taking lamotrigine. Lamotrigine plasma concentrations from 148 elderly patients (aged 59-92 years) were used to develop a population pharmacokinetic model. Data were analyzed using NONMEM. Model evaluation was performed using the bootstrap approach and predictive check. The results showed that the blood area nitrogen/serum creatinine ratio, weight, and phenytoin use significantly affect apparent clearance of lamotrigine, These results show that clinicians may need to take into account these covariates when dosing lamotrigine in this population.
引用
收藏
页码:455 / 463
页数:9
相关论文
共 29 条
[1]   Inherent correlation between dose and clearance in therapeutic drug monitoring settings: Possible misinterpretation in population pharmacokinetic analyses [J].
Ahn, JE ;
Birnbaum, AK ;
Brundage, RC .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2005, 32 (5-6) :703-718
[2]   Lamotrigine serum concentration-to-dose ratio: Influence of age and concomitant antiepileptic drugs and dosage implications [J].
Armijo, JA ;
Bravo, J ;
Cuadrado, A ;
Herranz, JL .
THERAPEUTIC DRUG MONITORING, 1999, 21 (02) :182-190
[3]   The effect of collinearity on parameter estimates in nonlinear mixed effect models [J].
Bonate, PL .
PHARMACEUTICAL RESEARCH, 1999, 16 (05) :709-717
[4]  
CASEY A E, 1968, Alabama Journal of Medical Sciences, V5, P474
[5]   Population pharmacokinetics of lamotrigine [J].
Chan, V ;
Morris, RG ;
Ilett, KF ;
Tett, SE .
THERAPEUTIC DRUG MONITORING, 2001, 23 (06) :630-635
[6]   LAMOTRIGINE, A NEW ANTICONVULSANT - PHARMACOKINETICS IN NORMAL HUMANS [J].
COHEN, AF ;
LAND, GS ;
BREIMER, DD ;
YUEN, WC ;
WINTON, C ;
PECK, AW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) :535-541
[7]   A LEISURELY LOOK AT THE BOOTSTRAP, THE JACKKNIFE, AND CROSS-VALIDATION [J].
EFRON, B ;
GONG, G .
AMERICAN STATISTICIAN, 1983, 37 (01) :36-48
[8]   Stability and performance of a population pharmacokinetic model [J].
Ette, EI .
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (06) :486-495
[9]   Population pharmacokinetics - III: Design, analysis, and application of population pharmacokinetic studies [J].
Ette, EI ;
Williams, PJ ;
Lane, JR .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (12) :2136-2144
[10]   Model appropriateness and population pharmacokinetic modeling [J].
Ette, EL ;
Williams, PJ ;
Kim, YH ;
Lane, JR ;
Liu, MJ ;
Capparelli, EV .
JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (06) :610-623